Comparison of JAK2 V617F burden quantitation by two different quantitative‐polymerase chain reaction methods
Authors:
- 24 June 2010
- journal article
- Published by Wiley in International Journal of Laboratory Hematology
- Vol. 32 (4) , 458-460
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Clinical relevance of JAK2 (V617F) mutant allele burdenHaematologica, 2009
- Concordance of assays designed for the quantification of JAK2V617F: a multicenter studyHaematologica, 2009
- Myeloproliferative disordersBlood, 2008
- Clinical correlates of JAK2V617F presence or allele burden in myeloproliferative neoplasms: a critical reappraisalLeukemia, 2008
- The JAK2 V617F allele burden in essential thrombocythemia, polycythemia vera and primary myelofibrosis – impact on disease phenotypeEuropean Journal of Haematology, 2007
- The quantitative JAK2 V617F neutrophil allele burden does not correlate with thrombotic risk in essential thrombocytosisLeukemia, 2007
- A JAK2 mutation in myeloproliferative disorders: pathogenesis and therapeutic and scientific prospectsTrends in Molecular Medicine, 2005
- Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disordersBlood, 2005